CAS NO: | 161928-86-5 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
生物活性 | GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2Dbmolecules at the RMA-S (Db Kb) cell surface with a SC50of 344 nM[1]. |
体外研究 (In Vitro) | GP(33-41) sensitizes MC57 and T2-Dbcells to lysis with ED50s of 0.9±0.6 and 2.5±0.7 nM[1].The interaction between T cell receptors (TCR) and peptide-major histocompatibility complex (pMHC) antigens can lead to varying degrees of agonism (T cell activation), or antagonism. The P14 TCR recognises the lymphocytic choriomeningitis virus (LCMV)-derived peptide, GP(33-41) (KAVYNFATC), presents in the context of H-2D[2]. |
分子量 | 1016.17 |
Formula | C46H69N11O13S |
CAS 号 | 161928-86-5 |
Sequence | Lys-Ala-Val-Tyr-Asn-Phe-Ala-Thr-Cys |
Sequence Shortening | KAVYNFATC |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |